JP Stock MarketDetailed Quotes

5714 DOWA Holdings

Watchlist
  • 4456.0
  • -2.0-0.04%
20min DelayMarket Closed Dec 30 15:30 JST
276.22BMarket Cap9.52P/E (Static)

DOWA Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

DOWA Holdings Q2 2025 Earnings Date

Currency：JPYNov 11, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
189.65B
163.60B
-26.05B
Miss Est.
+5.48%
-9.01%
-13.74%
EPS
108.96
146.76
+37.80
Beat Est.
+21.65%
+63.85%
+34.69%
Analyst Rating
Hold

Dec 12, 2024

DOWA Holdings Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 181.695B--
Feb 12, 20252025/Q3-- / 177.344B--
Nov 11, 20242025/Q2163.599B / 189.651B--
Aug 9, 20242025/Q1188.994B / 202.712B--
May 10, 20242024/Q4165.519B / 172.313B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 181.695B--
Feb 12, 20252025/Q3-- / 177.344B--
Nov 11, 20242025/Q2163.599B / 189.651B--
Aug 9, 20242025/Q1188.994B / 202.712B--
May 10, 20242024/Q4165.519B / 172.313B--

Unlock Free Earnings Estimates

DOWA Holdings Earnings Reports

  • DOWA Holdings: Confirmation letter

    Nov 12, 2024 20:02 ET

  • DOWA Holdings: Half Year Report - Term 122 (2024/04/01 - 2025/03/31)

    Nov 12, 2024 20:00 ET

  • DOWA Holdings: Notice regarding differences between consolidated earnings forecasts for the second quarter (interim period) and actual values

    Nov 11, 2024 01:00 ET

  • DOWA Holdings: 2024 2nd Quarter (Interim) Financial Results Supplementary Material

    Nov 11, 2024 01:00 ET

    • Read more

    Top JP Stock Gainers
    Symbol Price % Chg
    Kyogoku unyu shoji
    9073
    1599 +58.32%
    BlueMeme
    4069
    1337 +28.93%
    Estore
    4304
    1904 +26.60%
    Visumo
    303A
    2036 +24.45%
    D. Western Therapeutics Institute
    4576
    201 +23.31%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Dec 12, 2024

    Hold

    • Strong Buy

      0.00%

    • Buy

      0.00%

    • Hold

      85.71%

    • Underperform

      0.00%

    • Sell

      14.29%

    Price Target

    No Data